What is Hollison?
Hollison specializes in providing proven probiotics, precise application, and superior sampling solutions tailored for pet food manufacturers. The company's offerings are designed to enhance pet health and well-being by supporting gut health and immune function. Beyond its core probiotic solutions, Hollison also delivers automated sampling systems and customized engineering services aimed at optimizing operational efficiency for its clients. The company is committed to equipping pet food manufacturers with science-backed, bespoke solutions that ensure both product integrity and efficacy, positioning itself as a key partner in the pet nutrition industry.
How much funding has Hollison raised?
Hollison has raised a total of $315K across 2 funding rounds:
Debt
$150K
Debt
$165K
Debt (2020): $150K with participation from PPP
Debt (2021): $165K led by PPP
Key Investors in Hollison
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Hollison?
The substantial late-stage funding Hollison has received indicates a strong market position and a clear path toward scaling its operations and expanding its product development initiatives. This capital infusion is expected to fuel further innovation in its probiotic and sampling technologies, potentially leading to broader market penetration and the development of new solutions for the pet food industry. The strategic nature of the recent investment suggests a focus on enhancing Hollison's competitive advantage and solidifying its role as a leader in pet health and manufacturing solutions.
See full Hollison company page
